A clinical approach towards smell loss in Parkinson's disease

Journal of Parkinson's Disease

Volumn 4, Issue 2, 2014, Pages 189-195

  Haehner, Antje ^a   Hummel, Thomas ^a   Reichmann, Heinz ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Diagnosis; olfaction; Parkinson's disease; parkinsonism; smell

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; HUMAN; HYPOSMIA; OLFACTORY BULB; OLFACTORY HALLUCINATION; PARKINSON DISEASE; PAROSMIA; PERCEPTIVE THRESHOLD; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; SMELLING; COMPLICATION; MALE; OLFACTION DISORDERS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; OLFACTION DISORDERS; PARKINSON DISEASE;

EID: 84896544668     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130278     Document Type: Review

References (65)

1. Politis M, Wu K, Molloy S, Bain PG, Chaudhuri R, & Piccini P (2010) Parkinson's Disease symptoms: The Patient's Perspective. Mov Disord, 25, 1646-1651.
2. M̈uller A, Reichmann H, Livermore A, & Hummel T (2002) Olfactory function in idiopathic Parkinson's disease (IPD): Results from cross-sectional studies in IPD patients and longterm follow-up of de-novo IPD patients. J Neural Transm, 109, 805-811.
3. Doty RL, Deems D, & Steller S (1988) Olfactory dysfunction in Parkinson's disease: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology, 38, 1237-1244.
4. Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, Johnston AN, Mellick GD, Herting B, Reichmann H,&Hummel T (2009) Prevalence of smell loss in Parkinson's disease-a multicenter study. Parkinsonism Relat Disord, 15, 490-494.
5. Ward CD, Hess WA, & Calne DB (1983) Olfactory impairment in Parkinson's disease. Neurology, 33, 943-946.
6. Hummel T (1999) Olfactory evoked potentials as a tool to measure progression of Parkinson's Disease. In Focus on Medicine Vol. 14-New developments in the drug therapy of Parkinson's disease. Chase T, Bedard P (Eds), Blackwell Science, Oxford, UK, pp. 47-53.
7. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, &Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis. Mov Disord, 16, 41-46.
8. Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, & Moore RY (2007) Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease. J Neurol, 254, 84-90.
9. Bohnen NI, Gedela S, Herath P, Constantine GM, & Moore RY (2008) Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity. Neurosci Lett, 447, 12-16.
10. Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ,&HawkesCH(2010)Abasic smell test is as sensitive as a dopamine transporter scan: Comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease. QJM, 103, 941-952.
11. Berendse HW, Roos DS, Raijmakers P, & Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci, 310, 21-24.
12. Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, & Seppi K (2013) Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease. Brain, 136, 3028-3037.
13. Muller A, Mungersdorf M, Reichmann H, Strehle G,&Hummel T (2002) Olfactory function in Parkinsonian syndromes. J Clin Neurosci, 9, 521-524.
14. Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, & Hurtig H (1994) Olfactory function in Parkinson's disease subtypes. Neurology, 44, 266-268.
15. Iijima M, Kobayakawa T, Saito S, Osawa M, Tsutsumi Y, Hashimoto S,&Uchiyama S (2011) Differences in odor identification among clinical subtypes of Parkinson's disease. Eur J Neurol, 18, 425-429.
16. Katzen HL, Levin BE, & Weiner W (2006) Side and type of motor symptom influence cognition in Parkinson's disease. Mov Disord, 21, 1947-1953.
17. Oh JY, Kim YS, Choi BH, Sohn EH, & Lee AY (2009) Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD). Arch Gerontol Geriatr, 49, 351-354.
18. Damholdt MF, Borghammer P, Larsen L, & Ostergaard K (2011) Odor identification deficits identify Parkinson's disease patients with poor cognitive performance. Mov Disord, 26, 2045-2050.
19. Parrao T, Chana P, Venegas P, Behrens MI, & Aylwin ML (2012) Olfactory deficits and cognitive dysfunction in Parkinson's disease. Neurodegener Dis, 10, 179-182.
20. Goldstein DS, Sewell L, & Holmes C (2010) Association of anosmia with autonomic failure in Parkinson disease. Neurology, 74, 245-251.
21. Morley JF, & Duda JE (2011) Neuropsychological correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci, 310, 228-230.
22. Hawkes CH, & Shephard BC (1993) Selective hyposmia in Parkinson's disease? Lancet, 341, 435-436.
23. Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, & Halliday GM (2003) Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol, 60, 545-549.
24. Daum RF, Sekinger B, Kobal G, & Lang CJ (2000) Riechprufung mit "Sniffin' Sticks" zur klinischen Diagnostik des Morbus Parkinson. Nervenarzt, 71, 643-650.
25. Davidson TM, Freed C, HealyMP,&Murphy C (1998) Rapid clinical evaluation of anosmia in children: The Alcohol Sniff Test. Ann N Y Acad Sci, 855, 787-792.
26. Hummel T, Konnerth CG, Rosenheim K, & Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: Reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol, 110, 976-981.
27. Hummel T, Sekinger B,Wolf SR, Pauli E, & Kobal G (1997) "Sniffin' Sticks": Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses, 22, 39-52.
28. Kondo H, Matsuda T, Hashiba M,&Baba S (1998)Astudy of the relationship between the T&T olfactometer and the University of Pennsylvania Smell Identification Test in a Japanese population. Am J Rhinol, 12, 353-358.
29. Larsson M, Nilsson LG, Olofsson JK, & Nordin S (2004) Demographic and cognitive predictors of cued odor identification: Evidence from a population-based study. Chem Senses, 29, 547-554.
30. Ehrenstein WH, & Ehrenstein A (1999) Psychophysical methods. In Modern Techniques in Neuroscience Research, Windhorst U, Johansson H, eds. Springer, Berlin, pp. 1211-1241.
31. Lotsch J, Lange C, & Hummel T (2004) A simple and reliable method for clinical assessment of odor thresholds. Chem Senses, 29, 311-317.
32. Frasnelli J, & Hummel T (2005) Olfactory dysfunction and daily life. Eur Arch Otolaryngol, 262, 231-238.
33. Hummel T, & Kobal G (2001) Olfactory event-related potentials. In Methods and Frontiers in Chemosensory Research, Simon SA, Nicolelis MAL, eds. CRC Press, Boca Raton, Florida, pp. 429-464.
34. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, & Berendse HW (2004) Idiopathic hyposmia as preclinical sign of Parkinson's disease. Ann Neurol 56 173-181.
35. Ponsen MM, Stoffers D, Twisk JW,Wolters ECh,&Berendse HW (2009) Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study. Mov Disord, 24, 1060-1065.
36. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L,&WhiteLR(2008) Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol, 63, 167-173.
37. Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K, & Investigators PARS (2012) Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord, 27, 406-412.
38. Landis BN, & Burkhard PR (2008) Phantosmias and parkinson disease. Arch Neurol, 65, 1237-1239.
39. Hirsch AR (2009) Parkinsonism: The hyposmia and phantosmia connection. Arch Neurol, 66, 538-539; author reply 539.
40. Singh S, & Schwankhaus J (2009) Olfactory disturbance in parkinson disease. Arch Neurol, 66, 805; author reply 805-806.
41. Landis BN, Reden J, & Haehner A (2010) Idiopathic phantosmia: Outcome and clinical significance. ORL J Otorhinolaryngol Relat Spec, 72, 252-255.
42. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, & Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 24, 197-211.
43. Huisman E, Uylings HB, & Hoogland PV (2004) A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord, 19, 687-692.
44. Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, & Winkler J (2006) Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol, 197, 113-121.
45. Huisman E, Uylings HB, & Hoogland PV (2008) Genderrelated changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients. Mov Disord, 23, 1407-1413.
46. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, & Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand, 91, 247-250.
47. McKinnon JH, Demaerschalk BM, Caviness JN, Wellik KE, Adler CH, & Wingerchuk DM (2007) Sniffing out Parkinson disease: Can olfactory testing differentiate parkinsonian disorders? Neurologist, 13, 382-385.
48. Liberini P, Parola S, Spano PF, & Antonini L (1999) Olfactory dysfunction in dementia associated with Lewy bodies. Parkinsonism Relat Disord, 5, 30.
49. Williams SS,Williams J, CombrinckM,Christie S, SmithAD, & McShane R (2003) Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry, 80, 667-670.
50. Hawkes C (2003) Olfaction in neurodegenerative disorder. Mov Disord, 18, 364-372.
51. Katzenschlager R, & Lees AJ (2004) Olfaction and Parkinson's syndromes: Its role in differential diagnosis. Curr Opin Neurol, 17, 417-423.
52. Silveira-Moriyama L, Munhoz RP, de J, Carvalho M, Raskin S, Rogaeva E, de C, Aguiar P, Bressan RA, Felicio AC, Barsottini OG, Andrade LA, Chien HF, Bonifati V, Barbosa ER, Teive HA, & Lees AJ (2010) Olfactory heterogeneity in LRRK2 related Parkinsonism. Mov Disord, 25, 2879-2883.
53. Kr̈uger S, Haehner A, Thiem C, & Hummel T (2008) Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. J Neurol, 255, 1574-1579.
54. M̈uller A, Reuner U, Landis B, Kitzler H, Reichmann H, & Hummel T (2006) Extrapyramidal symptoms inWilson's disease are associated with olfactory dysfunction. Mov Disord, 21, 1311-1316.
55. Hummel T, & Nordin S (2005) Olfactory disorders and their consequences for quality of life-A review. Acta Oto-Laryngol, 125, 116-121.
56. Doty RL, Deems D, & Steller S (1988) Olfactory dysfunction in Parkinson's disease: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology, 38, 1237-1244.
57. R̈osser N, Berger K, Vomhof P, Knecht S, Breitenstein C, & Fl̈oel A (2008) Lack of improvement in odor identification by levodopa in humans. Physiol Behav, 93, 1024-1029.
58. Roth J, Radil T, Ruzicka E, Jech R,&Tichy J (1998) Apomorphine does not influence olfactory thresholds in Parkinson's disease. Funct Neurol, 13, 99-103.
59. Hummel T, Jahnke U, Sommer U, Reichmann H, & M̈uller A (2005) Olfactory function in patients with idiopathic Parkinson's disease: Effects of deep brain stimulation in the subthalamic nucleus. J Neural Transm, 112, 669-676.
60. Guo X, Gao G, Wang X, Li L, Li W, Liang Q, & Zhang H (2008) Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients. Stereotact Funct Neurosurg, 86, 237-244.
61. Fonoff ET, de Oliveira YS, Driollet S, Garrido GJ, de Andrade DC, Sallem F, Barbosa ER, & Teixeira MJ (2010) PET findings in reversible improvement of olfactory dysfunction after STN stimulation in a Parkinson's disease patient. Mov Disord, 25, 2466-2468.
62. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, & Heywood P (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med, 9, 589-595.
63. Haehner A, Tosch C, Wolz M, Klingelhoefer L, Fauser M, Storch A, Reichmann H, & Hummel T (2013) Olfactory training in patients with Parkinson's disease. PLoS One, 8, e61680.
64. Sobel N, Thomason ME, Stappen I, Tanner CM, Tetrud JW, Bower JM, Sullivan EV, & Gabrieli JD (2001) An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proc Natl Acad SciUS A, 98, 4154-4159.
65. Haehner A, Hummel T, Wolz M, Klingelḧofer L, Fauser M, Storch A, & Reichmann H (2013) Effects of rasagiline on olfactory function in patients with Parkinsońs disease. Mov Disord, doi: doi: 10.1002/mds.25661.